Close

Verona Pharma Announces Publication of Phase 2b Dose-Ranging COPD Data in the International Journal of Chronic Obstructive Pulmonary Disease

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/19/2024

1. NFLX
2. TSM
3. ISRG
4. INFY
5. SNV
6. TSLA
7. SMCI
8. SPY
9. SLB
10. PPG


Go back to Verona Pharma Announces Publication of Phase 2b Dose-Ranging COPD Data in the International Journal of Chronic Obstructive Pulmonary Disease
(NASDAQ: VRNA) Delayed: 15.65 -0.45 (2.8%)
Previous Close $16.10    52 Week High $ 
Open $16.02    52 Week Low $ 
Day High $16.20    P/E N/A 
Day Low $15.45    EPS $ 
Volume 196,044